ClinicalTrials.Veeva

Menu

Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Children

A

Ajou University School of Medicine

Status

Unknown

Conditions

Tonsillitis

Treatments

Drug: ropivacaine
Drug: normal saline

Study type

Interventional

Funder types

Other

Identifiers

NCT02848287
AJIRB-MED-DRU-16-061

Details and patient eligibility

About

Emergence agitation (EA) is highly prevalent in children after surgery. Risk factors for EA are Eye, nose and throat (ENT) surgery, preoperative anxiety, postoperative pain. There are several preventive strategies but none of them completely prevent EA.

Topical application of ropivacaine can reduce post-tonsillectomy pain. Therefore, it might reduce the incidence of postoperative EA.

Enrollment

84 estimated patients

Sex

All

Ages

3 to 6 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of anesthesiologist physical status class I/II
  • tonsillectomy or adenotonsillectomy under general anesthesia

Exclusion criteria

  • obstructive sleep apnea
  • developmental delay attention deficit hyperactivity disorder, allergy to local anesthetics, convulsion disorder

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

84 participants in 2 patient groups, including a placebo group

Normal Saline
Placebo Comparator group
Description:
1\*2 gauze is soaked with 5 cc of 0.9 % normal saline, applied in tonsillar fossae for 3 min, then removed.
Treatment:
Drug: normal saline
Ropivacaine
Experimental group
Description:
1\*2 gauze is soaked with 5 cc of 0.75% ropivacaine, applied in tonsillar fossae for 3 min, then removed.
Treatment:
Drug: ropivacaine

Trial contacts and locations

0

Loading...

Central trial contact

Go Un Roh, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems